The All of Us initiative, launched by the National Institutes of Health (NIH), seeks to gather health data from diverse populations across the United States, aiming to create a richer understanding of how individual differences affect health outcomes. The data collected provides a unique opportunity to explore the nuances of alcohol consumption in various demographics. The study’s findings, set to be published in the Journal of General Internal Medicine, forge a pathway for more inclusive and targeted treatments for AUD.

The researchers analyzed data from thousands of participants enrolled in the All of Us program, focusing specifically on those exhibiting signs of unhealthy alcohol use. Utilizing a comprehensive approach, they assessed not only the rates of diagnosis but also the treatments administered to individuals classified with AUD. This dual focus on diagnosis and treatment is crucial, as it exposes gaps in current practices that may hinder effective intervention.

The findings from this study are quite staggering. The researchers found that a significant percentage of participants with unhealthy alcohol use had not received a formal diagnosis of AUD. This raises red flags regarding the recognition and understanding of alcohol use issues within primary care settings. The lack of diagnosis indicates a systemic failure that could potentially deprive individuals of necessary care and resources.

Additionally, the study reveals critical disparities in treatment access and quality based on demographic factors, including race, socioeconomic status, and geographic location. Participants from marginalized communities were less likely to receive appropriate follow-up care, suggesting a considerable inequity in how AUD is perceived and treated. Such disparities can lead to a cascade of negative health outcomes, particularly in populations already burdened by health disparities.

Importantly, the study also evaluates the actual treatment options available to those diagnosed with AUD. While medications and therapies exist, many participants reported limited access to these treatments, highlighting another significant barrier in the battle against alcohol use disorders. The data points towards an urgent need for healthcare systems to adapt and expand their treatment methodologies to include more personalized options that cater to the unique needs of individuals facing AUD.

Furthermore, the findings underscore the importance of integrating mental health services into primary care settings. Many individuals struggling with unhealthy alcohol use also contend with underlying mental health issues, yet often these aspects remain untreated. By fostering a more holistic approach to healthcare, particularly for alcohol use disorders, providers can optimize patient outcomes through comprehensive care models that encompass both physical and mental health.

In their analysis, the research team emphasizes the vital role of training and education for healthcare professionals. There is a pressing need to equip providers with the necessary skills and knowledge to effectively diagnose and manage AUD. This recommendation is crucial in empowering clinicians to recognize not just the symptoms of alcohol use disorder, but also to engage in meaningful conversations with patients regarding their alcohol consumption habits.

Moreover, the researchers advocate for policy changes that would enhance funding for AUD treatment programs, particularly those targeting underrepresented communities. By redirecting resources to support community outreach and education on alcohol use, the aim is to reduce stigma and encourage individuals to seek help without fear or hesitation.

The evidence-based insights provided by this all-encompassing study shine a much-needed light on the current landscape of alcohol use disorder management. As the medical community moves forward into a new era of health care, the lessons from this research are imperative in reshaping approaches to diagnosing and treating AUD, ensuring that every individual receives the necessary support they deserve.

Lastly, as the All of Us program continues to expand its reach and data collection efforts, ongoing research stemming from these findings holds the potential to revolutionize our understanding of alcohol use and inform public health strategies on both a national and global scale. The fight against alcohol use disorders is complex and multifaceted, but with studies like this, there is hope for significant advancements toward better health outcomes for all individuals impacted.

In conclusion, the exploration of unhealthy alcohol use among All of Us participants serves as a clarion call to action for healthcare providers, policymakers, and communities alike. The findings open a dialogue to confront the persistent issues surrounding alcohol use and its associated disorders, urging stakeholders to prioritize equitable healthcare access and effective treatment solutions that are grounded in compassion and informed by the diversity of the populations they serve.

Subject of Research: Alcohol Use Disorder Diagnosis and Treatment

Article Title: Rates of Diagnosis and Treatment for Alcohol Use Disorder Among All of Us Participants with Unhealthy Alcohol Use

Article References:

Yue, Y., Rothberg, M.B., Back, S.E. et al. Rates of Diagnosis and Treatment for Alcohol Use Disorder Among All of Us Participants with Unhealthy Alcohol Use.
J GEN INTERN MED (2026). https://doi.org/10.1007/s11606-025-10089-5

Image Credits: AI Generated

DOI: https://doi.org/10.1007/s11606-025-10089-5

Keywords: Alcohol Use Disorder, All of Us, healthcare disparities, mental health, treatment accessibility

Coronary artery calcium is widely regarded as a robust indicator of coronary artery disease (CAD) risk, precisely quantifying the extent of calcified atherosclerotic plaque within the coronary vessels. These calcifications occur as cholesterol-rich plaques within the arterial walls mature and undergo a process of mineralization, rendering them visible through non-invasive imaging techniques such as computed tomography (CT). The greater the calcium burden detected, the higher the individual’s risk of obstructive coronary lesions potentially leading to ischemic events. Consequently, a CAC score of zero has traditionally been interpreted as evidence of the absence of clinically significant coronary atherosclerosis, signaling a low likelihood of imminent cardiac events.

Coronary atherosclerosis develops when lipids infiltrate the intimal layer of coronary arteries, triggering an inflammatory cascade that culminates in plaque formation. These plaques, composed of fibrous tissue, lipids, and inflammatory cells, progressively narrow the arterial lumen, compromising myocardial perfusion. A critical pathological event occurs when a plaque ruptures, exposing thrombogenic material to the bloodstream, rapidly precipitating thrombus formation. This occlusive event often manifests clinically as unstable angina or an acute myocardial infarction, contributing significantly to cardiovascular morbidity and mortality globally.

Using cardiac PET/CT scans as part of routine clinical evaluation in a cohort deemed at risk for CAD, the Intermountain Health team stratified over 40,000 patients based on their CAC scores. Among this extensive population, nearly 8,000 individuals exhibited no detectable coronary artery calcium, while the majority showed varying degrees of calcification. The study followed these subjects over a five-year period, meticulously tracking all-cause mortality to assess the prognostic value of CAC beyond traditional cardiovascular endpoints.

Statistical analysis revealed that individuals with any measurable CAC faced a two to threefold increased risk of death from all causes when compared to those with a CAC score of zero. Interestingly, the increased mortality associated with elevated CAC extended well beyond cardiovascular death, as approximately 75% of deaths in the CAC-positive group were attributed to non-cardiac conditions. This phenomenon underscores an unanticipated correlation between coronary calcification and generalized systemic health risks, prompting a paradigm shift in how CAC should be interpreted within clinical practice.

Dr. Jeffrey L. Anderson, the principal investigator and distinguished clinical researcher at Intermountain Health, emphasized the novelty of these findings. He posited that while the absence of CAC has long been regarded as indicative of optimal heart health, its predictive power might extend into broader dimensions of health status. The hypothesis emerging from this research suggests a possible systemic relationship whereby atherosclerotic burden in coronary arteries reflects the presence of generalized vascular pathology or even impairs intrinsic protective mechanisms such as immune surveillance mechanisms against malignancies.

One plausible mechanistic explanation for the observed associations involves the concept of systemic atherosclerosis, where calcified plaques in coronary arteries mirror similar pathological processes occurring within vascular beds throughout the body. This widespread vascular disease could contribute to multi-organ dysfunction, predisposing individuals to conditions beyond cardiovascular pathology. Furthermore, chronic inflammation linked to atherosclerosis may have deleterious effects on immune competence, potentially facilitating oncogenesis or other systemic illnesses.

This study’s retrospective design entailed rigorous evaluation of patient electronic health records, incorporating imaging data and subsequent mortality outcomes to paint a comprehensive picture of CAC’s prognostic significance. The utilization of PET/CT stress testing allowed for precise quantification of calcified plaque burden and provided a valuable tool for risk stratification that surpasses traditional risk factor assessments alone, such as lipid profiles or blood pressure measurements.

While these results pave the way for fascinating clinical and scientific exploration, several fundamental questions remain unresolved. Primarily, the mechanisms underlying the heightened risk of non-cardiovascular death in patients with elevated CAC are not yet delineated. This ambiguity highlights the need for prospective studies focusing on specific causes of mortality and examining potential confounding variables such as concurrent comorbidities, lifestyle factors, and genetic predispositions.

Looking forward, the Intermountain research team aims to deepen the investigation into the non-cardiovascular mortality causes among patients with coronary calcification. Understanding these pathways could unlock new interventions targeting systemic vascular health, immune function, and inflammation, possibly permitting earlier identification and management of patients at risk for a spectrum of life-threatening diseases.

The implications of these findings extend beyond cardiology, hinting at an integrative biomarker that encapsulates an individual’s overall health resilience. Clinicians might soon consider CAC scoring not only as a tool to predict heart attack risk but also as part of a holistic assessment that informs prognosis related to cancer, chronic infections, and other systemic disorders. Such an approach could transform preventive medicine paradigms and personalize healthcare strategies more effectively.

At the American Heart Association Scientific Sessions 2025, where this research was first unveiled, enthusiasm abounded for the potential clinical applications of coronary artery calcium scoring. The study represents a critical step in reimagining cardiovascular imaging biomarkers through a more expansive lens that crosses traditional disciplinary boundaries. It invites a future where quantifiable vascular imaging data could guide multifaceted health interventions with widespread impact.

Ultimately, the discovery that the absence of coronary artery calcium serves as a predictor of enhanced longevity and reduced vulnerability to myriad medical conditions is a compelling call for the medical community to revisit existing paradigms. As the research community embarks on unraveling the biological basis of this association, patients might one day benefit from tailored diagnostic insights that foresee and circumvent fatal illnesses beyond the heart.

Subject of Research: People
Article Title: Coronary Artery Calcium Score Predicts Broader Health Outcomes Beyond Cardiovascular Disease
News Publication Date: November 8, 2025
Image Credits: Intermountain Health
Keywords: Heart disease, Acute myocardial infarction, Coronary artery calcium, Cardiovascular risk, Atherosclerosis, Immune surveillance, Non-cardiovascular mortality, PET/CT imaging, Coronary plaque, All-cause mortality